Decrease in serum C-reactive protein levels by troglitazone is associated with pretreatment insulin resistance, but independent of its effect on glycemia, in type 2 diabetic subjects

Author: Yatagai T.   Nakamura T.   Nagasaka S.   Kusaka I.   Ishikawa S.-e.   Yoshitaka A.   Ishibashi S.  

Publisher: Elsevier

ISSN: 0168-8227

Source: Diabetes Research and Clinical Practice, Vol.63, Iss.1, 2004-01, pp. : 19-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content